Literature DB >> 16389723

Relationships between respiratory symptoms and FEV1 in men and women with normal lung function: The Korean Health and Genome Study.

Chol Shin1, Sungim Lee, Robert D Abbott, Je Hyeong Kim, Sang Yeub Lee, Kwang Ho In, KuChan Kimm.   

Abstract

Although the prevalence of chronic obstructive pulmonary disease (COPD) and its relationship with respiratory symptoms are well documented, few studies have focused on individuals with normal lung function, particularly in developed regions of Asia. The purpose of this report is to examine the relationship between respiratory symptoms and FEV1 in a population-based sample of Korean men and women with normal lung function. Subjects comprised 7518 individuals aged 40-69 years without airflow obstruction based on spirometric testing and in the absence of a medical history of pulmonary disease. Respiratory symptoms included chronic cough, chronic phlegm, wheezing, and shortness of breath. In men, the age-adjusted mean FEV1 was lower by 165 ml in smokers and 133 ml in nonsmokers in the presence versus the absence of wheezing (p < 0.05). While walking at a usual pace, FEV1 in smoking men was 210 ml lower in the presence versus the absence of shortness of breath (p < 0.05). Among nonsmoking men, overall shortness of breath and shortness of breath while walking uphill were associated with a lower FEV1 by 56 and 80 ml, respectively) versus those who reported having no shortness of breath (p < 0.05). Respiratory symptoms were unrelated to FEV1 in women smokers, although only 3.5% smoked cigarettes. In nonsmoking women, FEV1 was lower by an average of 89 ml in the presence versus the absence of wheezing (p < 0.001). Nonsmoking women also had a lower FEV1 in the presence of shortness of breath (overall, while at rest, and while walking uphill or at a usual pace, p < 0.001). Our findings suggest that respiratory symptoms are associated with a lower FEV1 in men and nonsmoking women with normal lung function. Whether respiratory symptoms can be used to identify individuals at risk for developing COPD needs further study.

Entities:  

Mesh:

Year:  2005        PMID: 16389723     DOI: 10.1007/s00408-004-2543-y

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  22 in total

1.  Relationship between FEV1 reduction and respiratory symptoms in the general population.

Authors:  N Jakeways; T McKeever; S A Lewis; S T Weiss; J Britton
Journal:  Eur Respir J       Date:  2003-04       Impact factor: 16.671

2.  Spirometry in the evaluation of pulmonary function.

Authors:  J F Morris
Journal:  West J Med       Date:  1976-08

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

4.  Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease.

Authors:  J Sunyer; J M Antó; D McFarlane; A Domingo; A Tobías; M A Barceló; A Múnoz
Journal:  Am J Respir Crit Care Med       Date:  1998-09       Impact factor: 21.405

Review 5.  Raising awareness of COPD in primary care.

Authors:  N F Voelkel
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

6.  Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors.

Authors:  Y Chen; K Breithaupt; N Muhajarine
Journal:  J Clin Epidemiol       Date:  2000-07       Impact factor: 6.437

7.  The effects of non-response in a prospective study of cancer: 15-year follow-up.

Authors:  L K Heilbrun; A Nomura; G N Stemmermann
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

8.  Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65.

Authors:  H W Glindmeyer; J J Lefante; C McColloster; R N Jones; H Weill
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

9.  Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles.

Authors:  N S Rawson; E Malcolm
Journal:  Stat Med       Date:  1995-12-30       Impact factor: 2.373

10.  Characteristics of respondents and nonrespondents in a prospective study of osteoporosis.

Authors:  L K Heilbrun; P D Ross; R D Wasnich; K Yano; J M Vogel
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

View more
  3 in total

1.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

2.  Breathlessness in Elderly Adults During the Last Year of Life Sufficient to Restrict Activity: Prevalence, Pattern, and Associated Factors.

Authors:  Miriam J Johnson; J Martin Bland; Evelyne A Gahbauer; Magnus Ekström; Aynharan Sinnarajah; Thomas M Gill; David C Currow
Journal:  J Am Geriatr Soc       Date:  2016-01       Impact factor: 5.562

Review 3.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.